Remi Murase
Hatanodai, 1428555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.
Journal: Clinical pharmacokinetics
Published: January 05, 2026
Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer.
Journal: Anticancer research
Published: November 20, 2025
Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 11, 2025
Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer.
Journal: Anticancer research
Published: August 30, 2024
Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: December 04, 2023
A polymorphism in ABCA2 is associated with neutropenia induced by capecitabine in Japanese patients with colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 05, 2023
Associations of HLA-C*01:02 and HLA-B*46:01 with regorafenib-induced erythema multiforme in Japanese patients with metastatic colorectal cancer.
Journal: Clinical and translational science
Published: May 28, 2023
Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy.
Journal: Anticancer research
Published: November 22, 2021
Anti-inflammatory effects of new catechin derivatives in a hapten-induced mouse contact dermatitis model.
Journal: European journal of pharmacology
Published: August 23, 2018
Last Updated: 09/26/2026